Abstract
Age-related macular degeneration (AMD) is the leading cause of blindness in the United States and has a significant impact on public health (1). Almost 1.8 million people have advanced AMD, which is defined as choroidal neovascularization (CNV) or geographic atrophy that results in scarring or visual loss in the central visual field (2,3). The advanced stages of AMD can be considered “end-stage” when the result is bilateral, untreatable macular scars causing central scotomata and associated moderate to profound visual impairment that limits a patient’s ability to engage in daily activities requiring good central vision. Advanced forms of AMD are associated with legal blindness, elevated risk of depression, reduced independence, increased risk of accidents, and a significant decrease in quality of life (4–6).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Gohdes DM, Balamurugan A, Larsen BA, Maylahn C. Age-related eye diseases: An emerging challenge for public health professionals. Prev Chronic Dis 2005;2:A17.
Friedman DS, O’Colmain BJ, Munoz B, et al. For the Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122:564–572.
Age-Related Eye Disease Study Research Group. Potential public health impact of age-related eye disease study results. AREDS Report no. 11. Arch Ophthalmol 2003;121:1621–1624.
Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SI. The psychosocial impact of macular degeneration. Arch Ophthalmol 1998;116:514–520.
Casten RJ, Rovner BW, Tasman W. Age-related macular degeneration and depression: a review of recent research. Curr Opin Ophthalmol 2004;15:181–183.
Brown MM, Brown GC, Sharma S, Kistler J, Brown H. Utility values associated with blindness in an adult population. Br J Ophthalmol 2001;85:327–331.
Lane SS, Kuppermann BD, Fine IH, et al. A prospective multicenter clinical trial to evaluate the safety and effectiveness of the Implantable Miniature Telescope. Am J Ophthalmol 2004;137:993–1001.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc., Totowa NJ
About this chapter
Cite this chapter
Hudson, H.L. (2007). A Telescope Prosthetic Device for Patients With End-Stage AMD. In: Tombran-Tink, J., Barnstable, C.J., Rizzo, J.F. (eds) Visual Prosthesis and Ophthalmic Devices. Ophthalmology Research. Humana Press. https://doi.org/10.1007/978-1-59745-449-0_17
Download citation
DOI: https://doi.org/10.1007/978-1-59745-449-0_17
Publisher Name: Humana Press
Print ISBN: 978-1-934115-16-9
Online ISBN: 978-1-59745-449-0
eBook Packages: MedicineMedicine (R0)